Response of Plasmodium falciparum to cotrimoxazole therapy: Relationship with plasma drug concentrations and dihydrofolate reductase and dihydropteroate synthase genotypes

American Journal of Tropical Medicine and Hygiene

Volumn 73, Issue 1, 2005, Pages 174-177

  Khalil, Insaf F ^a,b   Rønn, Anita M ^a   Alifrangis, Michael ^a,b   Gabar, Hytham A ^c   Jelinek, Thomas ^d   Satti, Gwiria M H ^e   Bygbjerg, Ib C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c UNIVERSITY OF KHARTOUM   (Sudan)

^d UNIVERSITY OF MUNICH   (Germany)

^e IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; DNA; SANAVITA; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; SUDAN; TREATMENT FAILURE; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 24644521052     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.73.174     Document Type: Article

References (13)

1. Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV, 2001. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 29: 1066-1067.
2. Jelinek T, Kilian A, Curtis J, Duraisingh M, Kabagambe G, Warhurst DP, 1999. Plasmodium falciparum: selection for Ser 108 of DHFR during treatment of uncomplicated malaria with cotrimoxazole in Ugandan children. Am J Trop Med Hyg 61: 125-130.
3. World Health Organization, 1996. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Geneva: World Health Organization. WHO/MAL/96.1077.
4. Khalil IF, Alifrangis M, Ronn AM, Gabar HA, Jelinek T, Satti GM, Bygbjerg IC, 2002. Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome. Am J Trop Med Hyg 67: 225-229.
5. Snounou G, Beck H, 1998. The use of PCR genotyping in the assessment of recrudescence or re-infection after antimalarial treatment. Parasitol Today 14: 462-461.
6. Rønn AM, Mutabingwa T, Kreisby S, Angelo HM, Fuursted K, Bygbjerg IC, 1999. A reversed phase high-pressure liquid chromatography method for the determination of cotrimoxazole (TRM/SMX) in children treated for malaria. Ther Drug Monit 21: 609-614.
7. Djimde A, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV, 2003. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 69: 558-563.
8. Wang P, Shinn O, Bayoumi R, Djimde A, Doumbo O, Swedbrg G, Daol L, Mshinda H, Hyde JE, 1997. Resistance to the antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthase and dihydrofolate reductase alleles in a large number of field samples of diverse origin. Mol Biochem Parasitol 89: 161-177.
9. Warhurst D, 2002. Resistance to antifolates in P. falciparum, the causative agent of tropical malaria. Sci Prog 85: 89-111.
10. Plowe C, Cortese J, Djimde A, Nwanyanwu O, Watkins W, Win-Stanley P, Estrada-Franco J, Mollinedo R, Avila J, Cespedes J, Carter D, Doumbo O, 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176: 1590-1596.
11. Kilian AH, Jelinek T, Prislin I, Kabagambe G, Byamukama W, Mpigika G, Korte R, von Sonnenburg F, 1998. Resistance in vivo of P. falciparum to cotrimoxazole in western Uganda. Trans R Soc Trop Med Hyg 92: 197-200.
12. Reeves D, Wilkinson P, 1979. The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues. Infection 7 (Supp 4): S330-S341.
13. Hansford C, Hoyland J, 1982. An evaluation of cotrimoxazole in the treatment of P. falciparum malaria. S Afr Med J 61: 512-514.